Legend Biotech Corporation ( (LEGN) ) has released its Q3 earnings. Here is a breakdown of the information Legend Biotech Corporation presented ...

Legend Biotech (LEGN) has released an update. Legend Biotech’s revenues soared in the third quarter of 2024, driven by the impressive ...

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of ...

Novavax has made a smaller splash in the U.S. Covid-19 vaccine market than it had hoped. But it's betting on licensing deals ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

FB Dermatology currently has operations in Italy and Australia with product sales throughout Europe, Australia and New Zealand. "This transaction is a powerful catalyst for Kane Biotech's growth,” ...

Medical Lubricants: Sales in this category dipped 2% year over year, attributed to standard fluctuations in order patterns, ...

Shares of the U.S. biotech firm fell 3% to $8.73. The U.S. vaccine maker now expects between $175 million and $225 million ...

Tagrisso sales were up 14% to $1.67 billion (17% at CER), Calquence ... marking one of the most extensive scandals in China’s ...

It is expected to rise at a compound annual growth rate of 10% in US dollar terms. South Korea's pharmaceutical sales are ...

Moderna shares jumped after the biotechnology company reported higher-than-expected sales of its Covid-19 vaccine and backed ...

Moderna reported earnings that exceeded expectations due to effective cost management but still has challenges related to its ...